BioRestorative Therapies, Inc.

BRTX Nasdaq CIK: 0001505497

Company Information

Industry Services-Misc Health & Allied Services, NEC
SIC Code 8090
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 40 MARCUS DRIVE, MELVILLE, NY, 11747
Mailing Address 40 MARCUS DRIVE, MELVILLE, NY, 11747
Phone (631) 760-8100
Fiscal Year End 1231
EIN 301341024

Financial Overview

FY2025

$1.51M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 26, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 23, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 18, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
8-K Current report of material events February 17, 2026 View on SEC
424B4 Prospectus for IPO or offering February 13, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 13, 2026 View on SEC
S-1/A IPO registration amendment February 10, 2026 View on SEC
S-1 IPO registration statement February 9, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment December 19, 2025 View on SEC

Annual Reports

10-K March 26, 2026
  • Lead program BRTX-100 received FDA 'Fast Track' status for chronic lower back disc disease.
  • Positive clinical trial data: 74% of patients showed improved function and 72% reported reduced pain.
View Analysis

Related Companies

Companies in the same industry (SIC: 8090)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.